Literature DB >> 30461533

Initiating drug therapy in early stage chronic obstructive pulmonary disease: does it impact the course and outcome?

Robert M Burkes1, Michael B Drummond.   

Abstract

PURPOSE OF REVIEW: Early chronic obstructive pulmonary disease (COPD) is emerging in importance for the clinical and research settings. This review will highlight a proposed definition of early COPD, examine early and midlife factors that lead to development of early COPD and review the literature pertaining to the treatment of mild COPD to gain insight into potential therapeutic approaches for early disease. RECENT
FINDINGS: Early COPD can be defined as disease occurring in patients younger than 50 years in age with a 10-pack-year or more smoking history and abnormal spirometry, imaging or lung function decline. Childhood exposures (maternal smoking and recurrent respiratory infections), childhood and adult asthma, and smoking affect middle-age lung function. Multiple studies of long-acting muscarinic antagonists (LAMAs) in mild COPD have shown improvements in lung function and symptoms scores. Smoking cessation also has a beneficial effect on longitudinal lung function.
SUMMARY: Early COPD is an important manifestation of COPD, with a newly proposed definition and associated risk factors identified. Inferring from studies on mild COPD cohorts, LAMAs and smoking cessation may have a positive effect on longitudinal lung function and symptomatic improvement.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30461533      PMCID: PMC6349494          DOI: 10.1097/MCP.0000000000000553

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  25 in total

1.  The Course of Lung Function in Middle-aged Heavy Smokers: Incidence and Time to Early Onset of Chronic Obstructive Pulmonary Disease.

Authors:  Hans Petersen; Akshay Sood; Francesca Polverino; Caroline A Owen; Victor Pinto-Plata; Bartolomé R Celli; Yohannes Tesfaigzi
Journal:  Am J Respir Crit Care Med       Date:  2018-12-01       Impact factor: 21.405

2.  Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.

Authors:  Enrico Heffler; Claudia Crimi; Salvatore Mancuso; Raffaele Campisi; Francesca Puggioni; Luisa Brussino; Nunzio Crimi
Journal:  Respir Med       Date:  2018-07-24       Impact factor: 3.415

3.  Efficacy of tiotropium in COPD patients with FEV1 ≥ 60% participating in the UPLIFT® trial.

Authors:  Donald P Tashkin; Bartolome R Celli; Marc Decramer; Theodore Lystig; Dacheng Liu; Steven Kesten
Journal:  COPD       Date:  2012-03-20       Impact factor: 2.409

Review 4.  Early chronic obstructive pulmonary disease: definition, assessment, and prevention.

Authors:  Stephen I Rennard; M Bradley Drummond
Journal:  Lancet       Date:  2015-05-02       Impact factor: 79.321

5.  Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease.

Authors:  Yumin Zhou; Nan-Shan Zhong; Xiaochen Li; Shuyun Chen; Jinping Zheng; Dongxing Zhao; Weimin Yao; Rongchang Zhi; Liping Wei; Bingwen He; Xiangyan Zhang; Changli Yang; Ying Li; Fenglei Li; Juan Du; Jianping Gui; Bin Hu; Chunxue Bai; Ping Huang; Gang Chen; Yongjian Xu; Changzheng Wang; Biao Liang; Yinhuan Li; Guoping Hu; Hui Tan; Xianwei Ye; Xitao Ma; Yan Chen; Xiwei Hu; Jia Tian; Xiaodan Zhu; Zhe Shi; Xiufang Du; Minjing Li; Shengming Liu; Ronghuan Yu; Jianping Zhao; Qianli Ma; Canmao Xie; Xiongbin Li; Tao Chen; Yingxiang Lin; Lizhen Zeng; Changxiu Ye; Weishu Ye; Xiangwen Luo; Lingshan Zeng; Shuqing Yu; Wei-Jie Guan; Pixin Ran
Journal:  N Engl J Med       Date:  2017-09-07       Impact factor: 91.245

6.  Outcomes of Childhood Asthma and Wheezy Bronchitis. A 50-Year Cohort Study.

Authors:  Nara Tagiyeva; Graham Devereux; Shona Fielding; Stephen Turner; Graham Douglas
Journal:  Am J Respir Crit Care Med       Date:  2016-01-01       Impact factor: 21.405

7.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

8.  Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Authors:  Marc Decramer; Bartolome Celli; Steven Kesten; Theodore Lystig; Sunil Mehra; Donald P Tashkin
Journal:  Lancet       Date:  2009-08-27       Impact factor: 79.321

9.  Exome Sequencing Analysis in Severe, Early-Onset Chronic Obstructive Pulmonary Disease.

Authors:  Dandi Qiao; Christoph Lange; Terri H Beaty; James D Crapo; Kathleen C Barnes; Michael Bamshad; Craig P Hersh; Jarrett Morrow; Victor M Pinto-Plata; Nathaniel Marchetti; Raphael Bueno; Bartolome R Celli; Gerald J Criner; Edwin K Silverman; Michael H Cho
Journal:  Am J Respir Crit Care Med       Date:  2016-06-15       Impact factor: 21.405

Review 10.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski
Journal:  Am J Respir Crit Care Med       Date:  2007-05-16       Impact factor: 21.405

View more
  3 in total

1.  Cytomegalovirus Seropositivity is Associated with Airflow Limitation in a Cohort of Veterans with a High Prevalence of Smoking.

Authors:  Robert Burkes; Andrew Osterburg; Timothy Hwalek; Laura Lach; Ralph J Panos; Michael T Borchers
Journal:  Chronic Obstr Pulm Dis       Date:  2021-10-28

2.  Age-Dependent Associations Between 25-Hydroxy Vitamin D Levels and COPD Symptoms: Analysis of SPIROMICS.

Authors:  Robert M Burkes; David J Couper; Igor Z Barjaktarevic; Christopher B Cooper; Wassim W Labaki; Meilan K Han; Prescott G Woodruff; Stephen C Lazarus; Trisha M Parekh; Robert Paine; Alejandro P Comellas; Russell P Bowler; Laura R Loehr; Nirupama Putcha; Robert A Wise; Todd T Brown; M Bradley Drummond
Journal:  Chronic Obstr Pulm Dis       Date:  2021-04-27

3.  Influence of Baduanjin on lung function, exercise capacity, and quality of life in patients with mild chronic obstructive pulmonary disease.

Authors:  Yang Yang; Keling Chen; Wenjun Tang; Xiaohong Xie; Wei Xiao; Jing Xiao; Xialing Luo; Wujun Wang
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.